Hopp til hovedinnhold
Toggle navigation
Live markets
Search
Search
Search
Search
My profile
My Subscriptions
Watchlists
Quote alerts
Create account
Sign in
NB
FR
EN
PT
NL
NB
DE
IT
Hjem
Company Press Releases
Company press releases
Abonner
Filtre
Filtre
Oppdater
Nullstill
Icon After
Dato
Toggle Visibility
Alle
I dag
Denne uken
Denne måneden
Tilpasset datosøk
Fra
Til
Kategori
Toggle Visibility
Alliances and agreements
Annen informasjonspliktig regulatorisk informasjon
Change in Capital
Commercial operations
Commercial results
Corporate life
Dividend
Eks.dato
Endringer i rettighetene til aksjer / verdipapirer
Flagging
General meeting / Board Meeting
Halvårsrapporter og revisjonsberetninger / uttalelser om forenklet revisorkontroll
Ikke-informasjonspliktige pressemeldinger
Income
Innsideinformasjon
Joint venture
Journal / appointments
Kapital- og stemmerettsendringer
Legal
Meetings / events
Meldepliktig handel for primærinnsidere
Mergers, Acquiqitions, Transferts
New
New establishment
News contracts
Other financial transaction
Other subject
Polls / Surveys
Products and services
Prospekt / opptaksdokument
Rapportering om betaling til myndigheter (land-for-land rapportering)
Rating
Renteregulering
Sales
Share history
Share introduction and issues
Takeover bids
Trends / Analyses
Utsteders meldeplikt ved handel i egne aksjer
Valg av hjemstat
Årsrapporter og revisjonsberetninger
Leverandør
Toggle Visibility
ActusNewsWire
BusinessWire
EQS Group
Euronext
GlobeNewswire
Les Echos
Marketwire
Modular Finance
Oslo Børs Newspoint
PR Newswire
Viser 1 - 50 av 97 resultater
Tid
Selskap
Tittel
Sektor
Kategori
19 Dec 2024
10:30 CET
EUROBIO-SCIENTIFIC
Eurobio Scientific : EB Development obtient une très large majorité du capital avec 88,9% détenus à l’issue de l’Offre Réouverte pour poursuivre son développement avec NextStage AM et IK Partners
20103010 Biotechnology
-
19 Dec 2024
10:30 CET
EUROBIO-SCIENTIFIC
Eurobio Scientific: EB Development obtains a significant majority of the capital with 88.9% held at the end of the Reopened Offer to continue its development with NextStage AM and IK Partners
20103010 Biotechnology
-
29 Nov 2024
15:30 CET
EUROBIO-SCIENTIFIC
Eurobio Scientific : succès de l’OPA à l’issue de sa première période, réouverture de l’offre du 4 au 17 décembre
20103010 Biotechnology
-
24 Oct 2024
18:00 CEST
EUROBIO-SCIENTIFIC
Eurobio Scientific : ouverture de l’offre publique d’achat jusqu’au 27 novembre
20103010 Biotechnology
-
23 Oct 2024
08:30 CEST
EUROBIO-SCIENTIFIC
Eurobio Scientific: Communiqué de mise à disposition du public des informations relatives aux caractéristiques notamment juridiques, financières et comptables de la société Eurobio Scientific SA
20103010 Biotechnology
-
23 Oct 2024
08:30 CEST
EUROBIO-SCIENTIFIC
COMMUNIQUÉ RELATIF À LA MISE À DISPOSITION DES INFORMATIONS RELATIVES AUX CARACTÉRISTIQUES, NOTAMMENT JURIDIQUES, FINANCIÈRES ET COMPTABLES D’EB DEVELOPMENT DANS LE CADRE DE L’OFFRE PUBLIQUE D’ACHAT VISANT LES ACTIONS D'EUROBIO SCIENTIFIC
20103010 Biotechnology
-
22 Oct 2024
16:34 CEST
EUROBIO-SCIENTIFIC
OFFRE PUBLIQUE D’ACHAT VISANT LES ACTIONS DE LA SOCIÉTÉ EUROBIO SCIENTIFIC INITIÉE PAR LA SOCIÉTÉ EB DEVELOPMENT - Communiqué de mise à disposition du public de la note en réponse de la société Eurobio Scientific SA
20103010 Biotechnology
-
22 Oct 2024
16:32 CEST
EUROBIO-SCIENTIFIC
Eurobio Scientific: COMMUNIQUÉ DU 22 OCTOBRE 2024 RELATIF À LA MISE À DISPOSITION DE LA NOTE D’INFORMATION DANS LE CADRE DE L’OFFRE PUBLIQUE D’ACHAT VISANT LES ACTIONS DE LA SOCIÉTÉ EUROBIO SCIENTIFIC INITIÉE PAR EB DEVELOPMENT
20103010 Biotechnology
-
16 Oct 2024
16:50 CEST
EUROBIO-SCIENTIFIC
Eurobio Scientific : levée de la dernière condition suspensive règlementaire au projet d’OPA initié par EB Development
20103010 Biotechnology
-
30 Sep 2024
17:35 CEST
EUROBIO-SCIENTIFIC
EB DEVELOPMENT : COMMUNIQUÉ DE PRESSE DU 30 SEPTEMBRE 2024 RELATIF AU DEPÔT D’UNE OFFRE PUBLIQUE D’ACHAT VISANT LES ACTIONS DE LA SOCIÉTÉ EUROBIO SCIENTIFIC
20103010 Biotechnology
-
30 Sep 2024
17:35 CEST
EUROBIO-SCIENTIFIC
Eurobio Scientific : COMMUNIQUÉ DU 30 SEPTEMBRE 2024 EN RÉPONSE AU PROJET D’OFFRE PUBLIQUE D’ACHAT VISANT LES ACTIONS DE EUROBIO SCIENTIFIC S.A. INITIÉE PAR LA SOCIÉTÉ EB DEVELOPMENT
20103010 Biotechnology
-
24 Sep 2024
18:00 CEST
EUROBIO-SCIENTIFIC
Eurobio Scientific : RESULTAT DU 1ER SEMESTRE 2024
20103010 Biotechnology
-
24 Sep 2024
18:00 CEST
EUROBIO-SCIENTIFIC
Eurobio Scientific: RESULTS FOR THE 1ST HALF OF 2024
20103010 Biotechnology
-
02 Aug 2024
07:30 CEST
EUROBIO-SCIENTIFIC
EUROBIO SCIENTIFIC COMPLETES ACQUISITION OF ENDOPREDICT® GENOMIC TEST FROM MYRIAD GENETICS
20103010 Biotechnology
-
02 Aug 2024
07:30 CEST
EUROBIO-SCIENTIFIC
EUROBIO SCIENTIFIC FINALISE L’ACQUISITION DU TEST GÉNOMIQUE ENDOPREDICT® AUPRÈS DE MYRIAD GENETICS
20103010 Biotechnology
-
01 Aug 2024
17:45 CEST
EUROBIO-SCIENTIFIC
Eurobio Scientific : suspension du contrat de liquidité
20103010 Biotechnology
-
31 Jul 2024
21:03 CEST
EUROBIO-SCIENTIFIC
Eurobio Scientific: CONCLUSION D’UN ACCORD ENTRE EUROBIO SCIENTIFIC ET UN CONSORTIUM MENÉ PAR L’ÉQUIPE D’ENTREPRENEURS ET DIRIGEANTS D’EUROBIO SCIENTIFIC, IK PARTNERS ET NEXTSTAGE AM EN VUE DU DÉPÔT D’UNE OFFRE PUBLIQUE D’ACHAT VOLONTAIRE A
20103010 Biotechnology
-
31 Jul 2024
21:03 CEST
EUROBIO-SCIENTIFIC
EUROBIO SCIENTIFIC: CONCLUSION OF AN AGREEMENT BETWEEN EUROBIO SCIENTIFIC AND A CONSORTIUM LED BY EUROBIO SCIENTIFIC'S TEAM OF ENTREPRENEURS AND MANAGERS, IK PARTNERS AND NEXTSTAGE AM WITH A VIEW TO FILE A VOLUNTARY TENDER OFFER AT A PRICE
20103010 Biotechnology
-
31 Jul 2024
21:01 CEST
EUROBIO-SCIENTIFIC
Eurobio Scientific : PREMIER SEMESTRE 2024, UN SOLIDE DEBUT D’EXERCICE DANS UN CONTEXTE INCERTAIN // PROJET D’OFFRE PUBLIQUE
20103010 Biotechnology
-
31 Jul 2024
21:01 CEST
EUROBIO-SCIENTIFIC
Eurobio Scientific: FIRST HALF 2024, A SOLID START TO THE FINANCIAL YEAR IN AN UNCERTAIN ENVIRONMENT // PROPOSED TENDER OFFER
20103010 Biotechnology
-
23 Jul 2024
11:30 CEST
EUROBIO-SCIENTIFIC
EUROBIO SCIENTIFIC : CALENDRIER DES PUBLICATIONS FINANCIÈRES DU 2EME SEMESTRE
20103010 Biotechnology
-
03 Jul 2024
17:45 CEST
EUROBIO-SCIENTIFIC
Eurobio Scientific : bilan semestriel du contrat de liquidité
20103010 Biotechnology
-
07 May 2024
18:30 CEST
EUROBIO-SCIENTIFIC
EUROBIO SCIENTIFIC SIGNS AN AGREEMENT TO ACQUIRE GENE EXPRESSION TEST FOR BREAST CANCER ENDOPREDICT®
20103010 Biotechnology
-
07 May 2024
18:30 CEST
EUROBIO-SCIENTIFIC
EUROBIO SCIENTIFIC SIGNE UN ACCORD POUR L'ACQUISITION DU TEST D'EXPRESSION GÉNIQUE POUR LE CANCER DU SEIN ENDOPREDICT®
20103010 Biotechnology
-
26 Apr 2024
17:45 CEST
EUROBIO-SCIENTIFIC
Eurobio Scientific : mise à disposition du rapport financier annuel 2023
20103010 Biotechnology
-
26 Apr 2024
17:40 CEST
EUROBIO-SCIENTIFIC
Eurobio Scientific : Rapport Financier Annuel 2023
20103010 Biotechnology
-
10 Apr 2024
17:40 CEST
EUROBIO-SCIENTIFIC
EUROBIO SCIENTIFIC: 2023 ANNUAL RESULTS
20103010 Biotechnology
-
10 Apr 2024
17:40 CEST
EUROBIO-SCIENTIFIC
EUROBIO SCIENTIFIC: RESULTAT ANNUEL 2023
20103010 Biotechnology
-
30 Jan 2024
17:45 CET
EUROBIO-SCIENTIFIC
Eurobio Scientific: FISCAL YEAR 2023, STRATEGIC TRANSFORMATION OF THE GROUP
20103010 Biotechnology
-
30 Jan 2024
17:45 CET
EUROBIO-SCIENTIFIC
Eurobio Scientific : EXERCICE 2023, CONFIRMATION DE LA TRANSFORMATION STRATEGIQUE
20103010 Biotechnology
-
17 Jan 2024
17:45 CET
EUROBIO-SCIENTIFIC
EUROBIO SCIENTIFIC CONFIRME SON ELIGIBILITE AU DISPOSITIF PEA-PME
20103010 Biotechnology
-
17 Jan 2024
17:45 CET
EUROBIO-SCIENTIFIC
Eurobio Scientific : BILAN SEMESTRIEL S2 DU CONTRAT DE LIQUIDITE
20103010 Biotechnology
-
10 Jan 2024
10:48 CET
EUROBIO-SCIENTIFIC
Eurobio Scientific : réduction de capital par annulation d’actions auto-détenues
20103010 Biotechnology
-
07 Nov 2023
17:40 CET
EUROBIO-SCIENTIFIC
Eurobio Scientific: CATHERINE COURBOILLET TO JOIN EUROBIO SCIENTIFIC BOARD AS AN INDEPENDENT MEMBER
20103010 Biotechnology
-
07 Nov 2023
17:40 CET
EUROBIO-SCIENTIFIC
Eurobio Scientific : NOMINATION DE CATHERINE COURBOILLET EN TANT QU’ADMINISTRATRICE INDEPENDANTE
20103010 Biotechnology
-
30 Oct 2023
17:45 CET
EUROBIO-SCIENTIFIC
Eurobio Scientific - MISE À DISPOSITION DU RAPPORT FINANCIER SEMESTRIEL 2023
20103010 Biotechnology
-
17 Oct 2023
17:40 CEST
EUROBIO-SCIENTIFIC
Eurobio Scientific : GenDx réduit à 3h la durée des tests de compatibilité d’organes
20103010 Biotechnology
-
17 Oct 2023
17:40 CEST
EUROBIO-SCIENTIFIC
Eurobio Scientific: GenDx reduces organ matching time to 3 hours
20103010 Biotechnology
-
11 Oct 2023
18:52 CEST
EUROBIO-SCIENTIFIC
Eurobio Scientific : Results for the First Half of 2023
20103010 Biotechnology
-
11 Oct 2023
18:52 CEST
EUROBIO-SCIENTIFIC
EUROBIO SCIENTIFIC : RESULTATS DU 1ER SEMESTRE 2023
20103010 Biotechnology
-
24 Jul 2023
19:45 CEST
EUROBIO-SCIENTIFIC
EUROBIO : ACCELERATION OF STRATEGIC DEPLOYMENT IN THE FIRST HALF OF 2023
20103010 Biotechnology
-
24 Jul 2023
17:46 CEST
EUROBIO-SCIENTIFIC
EUROBIO : ACCÉLÉRATION DU DÉPLOIEMENT STRATÉGIQUE AU PREMIER SEMESTRE 2023
20103010 Biotechnology
-
11 Jul 2023
07:30 CEST
EUROBIO-SCIENTIFIC
Eurobio Scientific: Capital reduction through cancellation of treasury shares
20103010 Biotechnology
-
11 Jul 2023
07:30 CEST
EUROBIO-SCIENTIFIC
Eurobio Scientific : Réduction de capital par annulation d’actions auto-détenues
20103010 Biotechnology
-
06 Jul 2023
17:45 CEST
EUROBIO-SCIENTIFIC
Eurobio Scientific : bilan semestriel du contrat de liquidité
20103010 Biotechnology
-
16 Jun 2023
17:45 CEST
EUROBIO-SCIENTIFIC
Eurobio Scientific: all resolutions approved at the Annual General Meeting
20103010 Biotechnology
-
16 Jun 2023
17:45 CEST
EUROBIO-SCIENTIFIC
Eurobio Scientific : l’assemblée générale approuve l’ensemble des résolutions
20103010 Biotechnology
-
13 Jun 2023
07:30 CEST
EUROBIO-SCIENTIFIC
Eurobio Scientific continues its international development with the acquisition of DID in Italy, Europe's third largest diagnostics market
20103010 Biotechnology
-
13 Jun 2023
07:30 CEST
EUROBIO-SCIENTIFIC
Eurobio Scientific poursuit son développement international avec l’acquisition de DID en Italie, 3e marché européen du diagnostic
20103010 Biotechnology
-
23 May 2023
17:45 CEST
EUROBIO-SCIENTIFIC
Eurobio Scientific becomes one of the first European companies to obtain IVDR1 CE marking of PCR tests
20103010 Biotechnology
-
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Sider
1
2
›
››
»
Last »
Company press releases subscription
×
To subscribe to Press releases from this issuer, visit the Subscription to Company news section in
Hjem
Markeder
Amsterdam
Cash Products
Aksjer
AEX index Stocks
AEX ESG Stocks
Indekser
Fond
Obligasjoner
ETF-er
Strukturerte produkter
Derivater
Indeksopsjoner
Indeksfutures
Aksjeopsjoner
Utbyttederivater
Aksjefutures
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Brussel
Cash products
Aksjer
Euronext regulated
Euronext Growth
Euronext Access
Expert Market
BEL 20 Stocks
Indekser
Obligasjoner
ETF-er
Strukturerte produkter
Derivater
Indeksfutures
Aksjeopsjoner
Aksjefutures
Utbyttederivater
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Expert Market
Dublin
Stocks
Euronext regulated
Euronext Growth
ISEQ 20 Stocks
Indices
Funds
Bonds
Irish Government Bonds
DOL
Lisboa
Cash Products
Aksjer
Euronext regulated
Euronext Access
PSI Stocks
Indekser
Obligasjoner
Derivater
Indeksfutures
Stock options
Aksjefutures
Utbyttederivater
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Milan
Cash Products
Stocks
Euronext Milan
Euronext Growth Milan
Euronext Star Milan
Euronext Global Equity Market
EuroTLX
Trading After Hours
MIB ESG Stocks
Bonds
MOT
Euronext Access Milan
EuroTLX
Structured Products
SeDeX
EuroTLX
ETFs
Funds
Derivative products
All derivatives
Index futures
Index options
Stock options
Stock futures
Dividend derivatives
Quote Vendor Codes
IPOs
Oslo
Aksjer, renter, indekser
Aksjer
Oslo Børs
Euronext Growth
Euronext Expand
Top performers
OBX aksjer
OBX ESG aksjer
OSEBX aksjer
OSEFX Aksjer
Seafood Aksjer
Shipping Aksjer
Aksjeindekser
Obligasjoner
Oslo Børs
Nordic Alternative Bond Market
Obligasjonsindekser
ETFer
Fond
Derivater
Derivative products
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Finanskalender
Primærinnsidere
Paris
Cash Products
Aksjer
Euronext regulated
Euronext Growth
Euronext Access
CAC 40 Stocks
CAC 40 ESG Stocks
Indekser
Obligasjoner
ETF-er
Strukturerte produkter
Derivater
Indeksfutures
Indeksopsjoner
Aksjeopsjoner
Aksjefutures
Utbyttederivater
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Aksjer
All Markets directories
All Markets
Euronext regulated
Euronext Growth
Euronext Access
Euronext Expand
Euronext Global Equity Market
EuroTLX
Trading After Hours
Selskapsmeldinger
Latest
Archive
Nye aksjenoteringer
Alle aksjenoteringer
Euronext Growth advisors
Euronext Tech Leaders
Family business
Indekser
Directory
Grønne indekser
Indices documents
Indices news
Indekser høringer
Kontakter Euronext-indekser
ETF-er
Directory
Grønne ETF-er
Fond
Directory
ESG Funds
Oslo Mutual Funds
Obligasjoner
Grønne obligasjoner
1.5° Bonds
All Markets directories
All Markets
Amsterdam
Brussels
Dublin
Lisbon
Oslo
Milan
Paris
Strukturerte produkter
Directory / search
Bid-Only trading status
Trading Turbos in the Netherlands
Derivater
Indeksfutures
Indeksopsjoner
Aksjeopsjoner
Aksjefutures
Utbyttederivater
ETF opsjoner
Kontraktsspesifikasjoner
Tick sizes
Rapportering av handler
Leverandørkoder markedsdata
Råvarer
Quotes
Quotes snapshot
Milling Wheat futures
Rapeseed futures
Corn futures
European Durum Wheat Futures
Milling Wheat options
Rapeseed options
Corn options
Bortfallskalendre
Bortfall
Wholesale Trading
Commitments of Traders (CoT) report
Kontraktsspesifikasjoner
Leverandørkoder markedsdata
DSP
Knowledge Centre
Bid & Ask
Options Investing E-learning
Contract Specifications
Position Management
Intrinsic Value
Premium & Valuation
Moneyness
Positions
Euronext News
Ressurser
Statistikk & rapporter
Quality of execution
Åpningstider
Kontraktsspesifikasjoner
Leverandørkoder markedsdata
Key Information Document
Class level
Product group level
Notices / Corporate actions
Cash Notices / Corporate actions
Derivatives corporate actions
All Corporate Actions
Latest
Unusual Contract Sizes, Dividends
Corporate Action Services
Corporate Action Policies
Derivatives notices
Markedshendelser
Suspenderte instrumenter
Stressed Market Conditions
Brudd på Double Cap limits
Ekstraordinære markedsforhold
Diverse meldinger
Market status
Medlemsliste
Issuers compliance
Hvor du finner hva